However, the results were not significantly changed by the “trim and fill” method, suggesting that the relationship of RASSF1A promoter methylation with HCC was meaningful, but not an artifact caused by unpublished negative studies. The gene discussed is RASSF1; the disease is hepatocellular carcinoma.